TAKEDA PATIENT SUPPORT Trademark

Trademark Overview

On Wednesday, January 19, 2022, a trademark application was filed for TAKEDA PATIENT SUPPORT with the United States Patent and Trademark Office. The USPTO has given the TAKEDA PATIENT SUPPORT trademark a serial number of 97227793. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Thursday, March 13, 2025. This trademark is owned by Takeda Pharmaceutical Company Limited. The TAKEDA PATIENT SUPPORT trademark is filed in the Communication Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring telecommunication internet access information to improve understanding by patients and caregivers about pharmaceuticals

Pharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve understanding by patients and caregivers about pharmaceuticals
takeda patient support

General Information

Serial Number97227793
Word MarkTAKEDA PATIENT SUPPORT
Filing DateWednesday, January 19, 2022
Status760 - EX PARTE APPEAL PENDING
Status DateThursday, March 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements

Description of MarkThe mark consists of a stylized red convex weighted line situated above a smaller stylized red convex line both positioned to frame the word "Takeda" in red, with the words "patient" and "support" underneath in purple, and a circular image of three human figures with arms extended in red, purple and teal.
Goods and ServicesPharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring telecommunication internet access information to improve understanding by patients and caregivers about pharmaceuticals
Indication of Colors claimedThe color(s) red, purple and teal is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve understanding by patients and caregivers about pharmaceuticals
NOT AVAILABLE"PATIENT SUPPORT"

Classification Information

International Class038 - Services allowing people to communicate with another by a sensory means.
US Class Codes100, 101, 104
Class Status Code6 - Active
Class Status DateMonday, June 12, 2023
Primary Code038
First Use Anywhere DateTuesday, November 23, 2021
First Use In Commerce DateTuesday, November 23, 2021
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2022
Primary Code044
First Use Anywhere DateTuesday, November 23, 2021
First Use In Commerce DateTuesday, November 23, 2021

Trademark Owner History

Party NameTakeda Pharmaceutical Company Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOsaka 541-0045
JP
Party NameTakeda Pharmaceutical Company Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOsaka 540-8645
JP

Trademark Events

Event DateEvent Description
Saturday, January 22, 2022NEW APPLICATION ENTERED
Tuesday, January 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 26, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, January 26, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, January 26, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, August 4, 2022ASSIGNED TO EXAMINER
Thursday, August 11, 2022NON-FINAL ACTION WRITTEN
Thursday, August 11, 2022NON-FINAL ACTION E-MAILED
Thursday, August 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 11, 2023FINAL REFUSAL WRITTEN
Tuesday, April 11, 2023FINAL REFUSAL E-MAILED
Tuesday, April 11, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, June 12, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, June 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 9, 2024USE AMENDMENT FILED
Friday, February 9, 2024TEAS STATEMENT OF USE RECEIVED
Sunday, March 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, March 3, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 11, 2024SU - NON-FINAL ACTION - WRITTEN
Thursday, April 11, 2024NON-FINAL ACTION E-MAILED
Thursday, April 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 30, 2024ASSIGNED TO LIE
Thursday, December 19, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 19, 2024SU - FINAL REFUSAL - WRITTEN
Thursday, December 19, 2024FINAL REFUSAL E-MAILED
Tuesday, March 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 13, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, March 13, 2025EXPARTE APPEAL RECEIVED AT TTAB
Thursday, March 13, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, March 13, 2025EX PARTE APPEAL-INSTITUTED
Thursday, March 13, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

support patient takeda information providing disease pharmaceuticals improve featuring understanding patients about pharmaceutical